![Enrique Poradosu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Enrique Poradosu
Fondatore presso NUVECTIS PHARMA, INC.
Patrimonio netto: 10 M $ in data 30/06/2024
Provenienza dei contatti di primo grado di Enrique Poradosu
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Subsidiary | Pharmaceuticals: Major | 35 | |
Subsidiary | Pharmaceuticals: Major | 13 | |
Public Company | Pharmaceuticals: Major | 7 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Enrique Poradosu tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
TG THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder Chief Executive Officer Director of Finance/CFO Director/Board Member Director/Board Member | |
Lirum Therapeutics, Inc.
![]() Lirum Therapeutics, Inc. BiotechnologyHealth Technology Lirum Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the treatment of deliberating diseases. The firm is also involved in the acquisition, development, and commercialization of drug candidates. Its products include LX-101, a targeted therapy directed to the insulin-like growth factor 1 (IGF-1R). The company was founded in November 2021 and is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
AMAG PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Investor Relations Contact Corporate Officer/Principal General Counsel | |
XTL BIOPHARMACEUTICALS LTD. | Medical Specialties | Director/Board Member Chairman Chief Executive Officer Director of Finance/CFO | |
CHECKPOINT THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Chief Executive Officer Director of Finance/CFO | |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
Ithaca College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
ACCESS Oncology, Inc.
![]() ACCESS Oncology, Inc. Pharmaceuticals: OtherHealth Technology Part of Akebia Therapeutics, Inc., ACCESS Oncology, Inc. is a company that develops pharmaceutical drugs. The company is based in New York, NY. The company was founded by Michael Sean Weiss. ACCESS Oncology was acquired by Keryx Biopharmaceuticals, Inc., part of Akebia Therapeutics, Inc. from December 13, 2018 on February 06, 2004 for $36.44 million. | Pharmaceuticals: Other | Chief Executive Officer President Director of Finance/CFO | |
Opus Point Partners Management LLC
![]() Opus Point Partners Management LLC Investment ManagersFinance Opus Point Partners Management LLC (OPPM) is a hedge fund manager headquartered in New York City. The firm was founded by Lindsay Rosenwald and Michael Weiss in 2009. They are owned by Opus Point Partners LLC, which is a subsidiary of Weiss & Co. LLC. OPPM manages investments that are dedicated to healthcare and life science. | Investment Managers | Chief Executive Officer Founder Director of Finance/CFO | |
Emory University | College/University | Graduate Degree Corporate Officer/Principal | |
The Trustees of Columbia University in The City of New York | College/University | Doctorate Degree Masters Business Admin | |
The Leonard N Stern School of Business | College/University | Masters Business Admin Masters Business Admin | |
IRONWOOD PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
The Hebrew University of Jerusalem | College/University | Undergraduate Degree Doctorate Degree | |
MESOBLAST LIMITED | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member | |
Deloitte & Touche LLP
![]() Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
The American Institute of Certified Public Accountants
![]() The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Siena College | College/University | Undergraduate Degree Undergraduate Degree | |
University of Massachusetts | College/University | Undergraduate Degree Undergraduate Degree | |
ALAUNOS THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Kidney Care Partners
![]() Kidney Care Partners Medical/Nursing ServicesHealth Services Kidney Care Partners provides healthcare services. It specializes in patient survival, hospitalization and patient experience with care. The company was founded in May 2003 and is headquartered in Washington, DC. | Medical/Nursing Services | Chairman Director/Board Member | |
Cornell University
![]() Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree | |
Columbia Law School | College/University | Graduate Degree Graduate Degree | |
Bar-Ilan University | College/University | Masters Business Admin Graduate Degree | |
ATARA BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
IDENIX PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Executive Officer Investor Relations Contact | |
AKEBIA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
CEREVEL THERAPEUTICS HOLDINGS, INC. | Pharmaceuticals: Major | Chief Executive Officer President | |
DYADIC INTERNATIONAL, INC. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
University of Michigan | College/University | Undergraduate Degree Undergraduate Degree | |
ACADIA REALTY TRUST | Real Estate Investment Trusts | Director/Board Member Director/Board Member | |
Baruch College | College/University | Masters Business Admin Undergraduate Degree | |
AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
American Kidney Fund, Inc.
![]() American Kidney Fund, Inc. Medical/Nursing ServicesHealth Services The American Kidney Fund provides treatment and financial assistance to patients with chronic kidney disease. It also provides assistance with expenses that insurance will not cover, such as transportation to dialysis, medications, special diet, kidney donor expenses, and other treatments. It also conducts specialty programs that help patients afford treatment during emergency travel and recover from natural disasters. The company was founded in 1971, and is headquartered in Rockville, MD. | Medical/Nursing Services | Chairman Director/Board Member | |
SEAGEN INC. | Pharmaceuticals: Major | Chief Operating Officer Corporate Officer/Principal | |
UNIQURE N.V. | Biotechnology | Director/Board Member Director/Board Member | |
NATIONAL HOLDINGS CORPORATION | Investment Banks/Brokers | Chairman Director/Board Member | |
AVENUE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
ORIGO ACQUISITION CORP | Financial Conglomerates | Chief Executive Officer Chairman | |
IMMUNOMEDICS, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
Cyprium Therapeutics, Inc.
![]() Cyprium Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Fortress Biotech, Inc., Cyprium Therapeutics, Inc. is an American New York-based company focused on developing novel therapies for the treatment of Menkes disease and related copper metabolism disorders. The company was granted FDA breakthrough therapy, fast track, and rare pediatric disease designations, as well as FDA orphan drug designation for both Cutx-101 and AAV-ATP7A. The European Medicines Agency also granted orphan drug designation to Cyprium. In March 2017, Cyprium entered into a cooperative research and development agreement with the Eunice Kennedy Shriver National Institute of Child Health and Human Development to advance the clinical development of Cutx-101 for the treatment of Menkes disease. In 2023, Cyprium completed the transfer of its proprietary rights and assigned its FDA documents pertaining to Cutx-101 to Sentynl Therapeutics, Inc. Cyprium and NICHD also previously entered into a worldwide, exclusive license agreement to develop and commercialize AAV-ATP7A gene therapy, which is currently in pre-clinical development. The company was founded in 2017 by Michael Sean Weiss, Lindsay Allan Rosenwald, and Lung S. Yam, who has been the CEO since then. | Miscellaneous Commercial Services | Founder Founder | |
Caelum Biosciences, Inc.
![]() Caelum Biosciences, Inc. BiotechnologyHealth Technology Caelum Biosciences, Inc. operates as a clinical-stage biotechnology company developing treatments for rare and life-threatening diseases. The company was founded in January 2017 and is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member | |
State University of New York at Albany | College/University | Undergraduate Degree Undergraduate Degree | |
FORTRESS BIOTECH, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
KPMG LLP
![]() KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor Corporate Officer/Principal | |
Baergic Bio, Inc.
![]() Baergic Bio, Inc. Pharmaceuticals: MajorHealth Technology Baergic Bio, Inc. develops therapeutic drugs for the treatment of central nervous system disorders. It offers oncology, rare diseases, and gene therapy. The company is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
MUSTANG BIO, INC. | Pharmaceuticals: Major | Director/Board Member Chairman |
Statistiche
Distribuzione geografica
Stati Uniti | 45 |
Israele | 4 |
Paesi Bassi | 3 |
Australia | 2 |
Settori
Health Technology | 27 |
Consumer Services | 14 |
Finance | 5 |
Commercial Services | 5 |
Health Services | 4 |
Posizioni
Director/Board Member | 191 |
Corporate Officer/Principal | 89 |
Independent Dir/Board Member | 67 |
Director of Finance/CFO | 56 |
Undergraduate Degree | 47 |
Contatti più connessi
Insiders | |
---|---|
Uri Ben-Or | 32 |
J. Buchi | 26 |
Michael Weiss | 25 |
Ronald Renaud | 24 |
Lindsay Rosenwald | 23 |
Joseph Feczko | 23 |
Eric Rose | 21 |
Kevin Cameron | 17 |
BILL Kessler | 16 |
Darren Cline | 15 |
Wyche Fowler | 15 |
Eric Dobmeier | 14 |
Daniel Hume | 14 |
Abraham Ceesay | 13 |
Ronald Bentsur | 13 |
- Borsa valori
- Insiders
- Enrique Poradosu
- Connessioni Società